<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01464502</url>
  </required_header>
  <id_info>
    <org_study_id>11/LO/1879</org_study_id>
    <nct_id>NCT01464502</nct_id>
  </id_info>
  <brief_title>Pressure Wire Guided Cardiac Resynchronisation Therapy</brief_title>
  <official_title>A Prospective Randomised Controlled Trial of Cardiac Resynchronisation Therapy Guided by Invasive dP/dT: Radi-CRT Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guy's and St Thomas' NHS Foundation Trust</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>St. Jude Medical</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Guy's and St Thomas' NHS Foundation Trust</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Heart failure patients may benefit from having a special pacemaker implanted that can make
      the heart pump in a more coordinated and efficient way Cardiac Resynchronisation Therapy
      (CRT). For the heart to pump well it is necessary for the pacing wires to be placed in
      optimal positions. Only two thirds of people respond to CRT and this may be because of
      non-ideal pacing wire position. A potential marker for response is the change in heart pump
      pressure change over time. The aim of this study is to use a specialised wire in the main
      pumping chamber of the heart to record the pressure changes with the pacing lead in various
      positions to determine the optimal position. It is postulated that the improved pressure
      changes will increase the proportion of responders.

      Pilot study work has shown that the work is technically feasible and safe. The initial data
      has been published in a highly regarded scientific journal. This main study will be a
      multicentre randomised controlled trial whereby patients will be randomised to either
      standard treatment or pressure wireguided treatment. The patients in the pressurewire guided
      arm will have a specialised wire implanted into the main pumping chamber of their heart via a
      blood vessel at the top of the leg (or less commonly a blood vessel in the wrist). This will
      measure acute pressure changes over time and the pacing lead will be positioned in the site
      that gives the greatest change in pressure.

      If the patients in the pressurewire guided arm fare better than those receiving standard
      treatment it may alter how a large proportion of heart failure patients are treated around
      the world. The study requires 282 patients and is likely to take two years to complete.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2012</start_date>
  <completion_date type="Anticipated">April 2018</completion_date>
  <primary_completion_date type="Anticipated">April 2018</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in the proportion of CRT responders at 6 months</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Change in clinical composite score at 6 months</measure>
    <time_frame>6 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Change in echo derived endsystolic volume (ESV) at six months</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in echo derived enddiastolic colume (EDV) at six months</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in echo derived left ventricular ejection fraction (LVEF) at 6 months</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Six month assessment of change in symptoms (Minnesota Living with Heart Failure Questionnaire)</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Six month change in 6 minute walk distance</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Six month change in VO2 max (CPET)</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Six month change in ntProBNP</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Six month difference in hospital readmission (days)</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Six month difference in mortality</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in rates of successful LV lead implantation</measure>
    <time_frame>One week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in procedure duration</measure>
    <time_frame>One week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in radiation dose</measure>
    <time_frame>One week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Difference in contrast dose</measure>
    <time_frame>One week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Procedural complications</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">282</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Standard CRT Implant</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Pressure-wire guided CRT Implant</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Standard CRT Implant</intervention_name>
    <arm_group_label>Standard CRT Implant</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Pressure-wire guided CRT implant</intervention_name>
    <description>A pressure wire will be sited in the left ventricle to measure dP/dT max. The LV lead position that gives the highest dP/dT max will be the final position used.</description>
    <arm_group_label>Pressure-wire guided CRT Implant</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients fulfilling standard criteria for CRT

          -  Ischaemic or non-ischaemic heart failure

        Exclusion Criteria:

          -  Contraindication to pressure wire assessment including:

          -  Severe aortic valve disease

          -  Mechanical aortic valve replacement

          -  Severe peripheral vascular disease

          -  LV thrombus
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Manav Sohal, BSc, MBBS</last_name>
    <phone>00447939061486</phone>
    <email>manav.sohal@gstt.nhs.uk</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Christopher Aldo Rinaldi, MBBS, MD</last_name>
    <email>aldo.rinaldi@gstt.nhs.uk</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Auxolgico</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Giovanni Prerego, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>San Rafaelle Hospital</name>
      <address>
        <city>Milan</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicoleta Sora, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Medway Maritime Hospital</name>
      <address>
        <city>Gillingham</city>
        <state>Kent</state>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shaumik Adhya, MBBS</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Queen Elizabeth Hospital Birmingham</name>
      <address>
        <city>Birmingham</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Francisco Leyva, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Royal Bournemouth Hospital</name>
      <address>
        <city>Bournemouth</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>John Paisey</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Guy's and St. Thomas' NHS Foundation NHS Trust</name>
      <address>
        <city>London</city>
        <zip>SE1 7EH</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Manav Sohal, BSc, MBBS</last_name>
      <phone>00447939061486</phone>
      <email>manav.sohal@gstt.nhs.uk</email>
    </contact>
    <investigator>
      <last_name>Manav Sohal, BSc, MBBS</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Queen Elizabeth Hospital Woolwich</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shoaib Hamid, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Heart Hospital</name>
      <address>
        <city>London</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pier Lambiase, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Freeman Hospital</name>
      <address>
        <city>Newcastle upon Tyne</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Janet McCoomb, MD</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>John Radcliffe Hospital</name>
      <address>
        <city>Oxford</city>
        <country>United Kingdom</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tim Betts, MD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Italy</country>
    <country>United Kingdom</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 31, 2011</study_first_submitted>
  <study_first_submitted_qc>November 1, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 3, 2011</study_first_posted>
  <last_update_submitted>April 3, 2017</last_update_submitted>
  <last_update_submitted_qc>April 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Guy's and St Thomas' NHS Foundation Trust</investigator_affiliation>
    <investigator_full_name>Manav Sohal</investigator_full_name>
    <investigator_title>Research Fellow</investigator_title>
  </responsible_party>
  <keyword>Heart failure</keyword>
  <keyword>Cardiac resynchronisation therapy</keyword>
  <keyword>Acute haemodynamic response</keyword>
  <keyword>Responder</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

